2026-07-01Neutral
+20.58%weekly changeMerck KGaA announced a definitive agreement to acquire Bio-Techne for $73.00 per share in an all-cash transaction.
read the report →Bio-Techne Corporation is a global life sciences company that develops, manufactures, and markets high-quality reagents, analytical instruments, and precision diagnostic tools.
stitched from the price window carried by each report
Merck KGaA announced a definitive agreement to acquire Bio-Techne for $73.00 per share in an all-cash transaction.
read the report →Merck KGaA announced a definitive agreement to acquire Bio-Techne for $73.00 per share in an all-cash transaction.
read the report →Merck KGaA announced a definitive agreement to acquire Bio-Techne for $73.00 per share in cash.
read the report →